476 related articles for article (PubMed ID: 20813341)
1. Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.
Okonkwo OC; Alosco ML; Jerskey BA; Sweet LH; Ott BR; Tremont G;
Alzheimers Dement; 2010 Sep; 6(5):404-11. PubMed ID: 20813341
[TBL] [Abstract][Full Text] [Related]
2. Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.
Whitehair DC; Sherzai A; Emond J; Raman R; Aisen PS; Petersen RC; Fleisher AS;
Alzheimers Dement; 2010 Sep; 6(5):412-9. PubMed ID: 20813342
[TBL] [Abstract][Full Text] [Related]
3. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
Chen XR; Shao Y; Sadowski MJ;
J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
[TBL] [Abstract][Full Text] [Related]
4. Five-Year Longitudinal Brain Volume Change in Healthy Elders at Genetic Risk for Alzheimer's Disease.
Reiter K; Nielson KA; Durgerian S; Woodard JL; Smith JC; Seidenberg M; Kelly DA; Rao SM
J Alzheimers Dis; 2017; 55(4):1363-1377. PubMed ID: 27834774
[TBL] [Abstract][Full Text] [Related]
5. Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.
Cechova K; Andel R; Angelucci F; Chmatalova Z; Markova H; Laczó J; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Ward DD; Hort J
J Alzheimers Dis; 2020; 73(1):247-257. PubMed ID: 31771052
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
7. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
[TBL] [Abstract][Full Text] [Related]
8. Differential Effect of APOE ɛ4 Status and Elevated Pulse Pressure on Functional Decline in Cognitively Normal Older Adults.
Werhane ML; Thomas KR; Edmonds EC; Bangen KJ; Tran M; Clark AL; Nation DA; Gilbert PE; Bondi MW; Delano-Wood L;
J Alzheimers Dis; 2018; 62(4):1567-1578. PubMed ID: 29562507
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort.
Risacher SL; Shen L; West JD; Kim S; McDonald BC; Beckett LA; Harvey DJ; Jack CR; Weiner MW; Saykin AJ;
Neurobiol Aging; 2010 Aug; 31(8):1401-18. PubMed ID: 20620664
[TBL] [Abstract][Full Text] [Related]
10. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.
Jack CR; Shiung MM; Gunter JL; O'Brien PC; Weigand SD; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Cha RH; Tangalos EG; Petersen RC
Neurology; 2004 Feb; 62(4):591-600. PubMed ID: 14981176
[TBL] [Abstract][Full Text] [Related]
12. Semantic memory activation in amnestic mild cognitive impairment.
Woodard JL; Seidenberg M; Nielson KA; Antuono P; Guidotti L; Durgerian S; Zhang Q; Lancaster M; Hantke N; Butts A; Rao SM
Brain; 2009 Aug; 132(Pt 8):2068-78. PubMed ID: 19515831
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.
Basta M; Zaganas I; Simos P; Koutentaki E; Dimovasili C; Mathioudakis L; Bourbouli M; Panagiotakis S; Kapetanaki S; Vgontzas A
J Alzheimers Dis; 2021; 79(2):763-771. PubMed ID: 33361595
[TBL] [Abstract][Full Text] [Related]
14. Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline.
Hochstetler H; Trzepacz PT; Wang S; Yu P; Case M; Henley DB; Degenhardt E; Leoutsakos JM; Lyketsos CG
J Alzheimers Dis; 2016; 50(1):271-82. PubMed ID: 26639960
[TBL] [Abstract][Full Text] [Related]
15. Comparing predictors of conversion and decline in mild cognitive impairment.
Landau SM; Harvey D; Madison CM; Reiman EM; Foster NL; Aisen PS; Petersen RC; Shaw LM; Trojanowski JQ; Jack CR; Weiner MW; Jagust WJ;
Neurology; 2010 Jul; 75(3):230-8. PubMed ID: 20592257
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
17. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease.
Okonkwo OC; Alosco ML; Griffith HR; Mielke MM; Shaw LM; Trojanowski JQ; Tremont G;
Arch Neurol; 2010 Jun; 67(6):688-96. PubMed ID: 20558388
[TBL] [Abstract][Full Text] [Related]
19. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
[TBL] [Abstract][Full Text] [Related]
20. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
